enoximone has been researched along with Cardiomyopathies, Primary in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beutlhauser, T; Erb, J; Feldheiser, A; Grubitzsch, H; Schuster, B; Spies, C; Treskatsch, S | 1 |
| Berti, S; Biagini, A; Bonini, R; Clerico, A; Ferrazzi, P; Iascone, MR; Iervasi, G; Manfredi, C; Palmieri, C; Ravani, M | 1 |
| Robin, NM; Wenstone, R | 1 |
| Bethke, T; Eschenhagen, T; Klimkiewicz, A; Kohl, C; Mehl, H; Mende, U; Meyer, W; Neumann, J; Rosswag, S; von der Leyen, H | 1 |
| Beurrier, D; Bock, F; Brembilla-Perrot, B; Danglas, P | 1 |
| Reddy, PS; Uretsky, BF; Valdes, AM | 1 |
| Hakki, A; Iskandrian, AS; Likoff, MJ; Ulrich, S | 1 |
| Bonzel, T; Hasenfuss, G; Heiss, WH; Holubarsch, C; Just, H; Meinertz, T | 1 |
1 review(s) available for enoximone and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
Topics: Administration, Oral; Animals; Cardiomyopathies; Cardiotonic Agents; Dobutamine; Dogs; Enoximone; Heart Failure; Heart Rate; Hemodynamics; Hormones; Humans; Imidazoles; Injections, Intravenous; Kinetics; Lactates; Myocardial Contraction; Time Factors; Vasodilation | 1986 |
2 trial(s) available for enoximone and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.
Topics: Aged; Aged, 80 and over; Blood Pressure; Cardiomyopathies; Cardiotonic Agents; Coronary Artery Bypass; Double-Blind Method; Enoximone; Female; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Norepinephrine; Prospective Studies; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Vasoconstrictor Agents; Ventricular Dysfunction, Left | 2014 |
[Electrophysiologic effects of enoximone].
Topics: Aged; Cardiomyopathies; Cardiotonic Agents; Drug Evaluation; Electrophysiology; Enoximone; Heart Conduction System; Humans; Imidazoles; Middle Aged; Tachycardia; Tachycardia, Supraventricular | 1990 |
5 other study(ies) available for enoximone and Cardiomyopathies, Primary
| Article | Year |
|---|---|
Acute enoximone effect on systemic and renal hemodynamics in patients with heart failure.
Topics: Adult; Aged; Aged, 80 and over; Aldosterone; Atrial Natriuretic Factor; Cardiomyopathies; Cardiotonic Agents; Enoximone; Female; Hemodynamics; Humans; Infusions, Intravenous; Kidney; Kidney Function Tests; Male; Middle Aged; Renal Circulation; Renin | 1996 |
The use of enoximone in peripartum cardiomyopathy.
Topics: Adult; Cardiomyopathies; Cardiotonic Agents; Enoximone; Female; Humans; Pregnancy; Pregnancy Complications, Cardiovascular | 1998 |
Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts.
Topics: Adult; Cardiomyopathies; Chromatography, DEAE-Cellulose; Enoximone; Female; Heart; Humans; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Ouabain; Phosphodiesterase Inhibitors | 1992 |
Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathies; Cardiomyopathy, Dilated; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged | 1986 |
Influence of phosphodiesterase inhibition on myocardial energetics in dilative cardiomyopathy.
Topics: Cardiomyopathies; Cardiotonic Agents; Enoximone; Heart; Heart Rate; Humans; Imidazoles; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors | 1987 |